Active Substance Master File Submissions

 

Active Substance Master File Submissions - Overview

An Active Substance Master File (ASMF), formerly known as European Drug Master File (EDMF) submission, is not a mandatory requirement for the European Union (EU) Health Authorities (HAs), as it is reviewed only in connection with a Marketing Authorization Application (MAA). Active substance (Active Pharmaceutical Ingredient [API]) manufacturers/Active Substance Master File holders can directly submit the ASMFs to the EU HAs as per the submission procedure identified by the MAA holder.

To avoid administrative comments/rejection of an MAA due to the non-availability of the ASMF and to receive timely MAA approval, submission of the Active Substance Master File as per the EU-specific requirements (ASMF guidelines) is crucial. The ASMF holder can provide a Letter of Authorization (LoA) to multiple MAA holders as a reference in multiple applications. Freyr’s expertise in handling the ASMF submissions and their lifecycle management is listed below:

Active Substance Master File Submissions

  • Regulatory support in identifying the starting material and intermediates.
  • Active Substance Master File Procedure.
  • Guidance on selecting the route of synthesis for APIs.
  • Support in designing the limits for impurities in starting materials, intermediates, and their carry-over to APIs.
  • Designing specifications for starting materials, in-process, intermediates, and active substances.
  • Offering support to an ASMF holder in setting the control strategy and limits for genotoxic impurities and elemental impurities in intermediates or in the active substance.
  • Guidance on designing the protocols for stability studies, process validation, hold-time study, and forced degradation studies for ASMF submission.
  • Review of manufacturing details of starting materials for adequacy in ASMF.
  • Preparation, review, and Active Substance Master File submission to avoid any delays.
  • Publishing EMA’s ASMFs in the eCTD format as per the current EU guidelines.
  • Regulatory strategy, preparation, and submission of variations and renewals for registered ASMFs.
  • Regulatory strategy, preparation, and ASMF submission responses to HA queries.
Active Substance Master File Submissions
  • ASMF Submission.
  • ASMF Procedure.
  • European Drug Master File (EDMF).
  • Active Substance Master File Guidance.
  • Guideline on Active Substance Master File Procedure.
  • ASMF Guideline.
  • Active Substance Master File Submission.
  • Active Pharmaceutical Ingredient Approval.
Active Substance Master File Submissions

Celebrating Customers Success

 

Medicinal Products

Regulatory Affairs

India

Thank you for the timely support over the weekend, which allowed us to resubmit quickly after being notified. This continuously demonstrates Freyr's commitment towards our company’s milestones.

Director - Global Regulatory Affairs – Operations

India-based, Global Top Generic Pharma Company

 

Medicinal Products

Publishing

UK

I am sure you have heard by now that we have received our first-ever approval from the FDA for our Brands division. This is a major milestone for us as well as for my team here in Reg Ops. I would be remiss if I didn’t point out that we would not have been able to do this without the help of your dedicated team. From the original filing, then the following year of responses, all helped get us to final approval.

Thank you Freyr team for a job well done!

Sr. Director, Head of Regulatory Operations

Ireland-based, Global Specialty Pharmaceutical Company

 

Medicinal Products

Regulatory Affairs

USA

Please relate to the team the excellent job they have done on the IND reactivation. Specifically, the high-quality module 3, written by Freyr. It was very comprehensive, very few revisions were required, and we had no questions from Health Canada or FDA. No CMC questions: that was a first for me. So very responsive to my many requests, which I am sure can be frustrating but always helpful while producing excellent work.

Thank you for always being available and responding quickly and comprehensively to all my requests.

What a great team you have, Freyr.

Lynne McGrath

Regulatory Consultant

 

Medicinal Products

Regulatory Affairs

USA

Congratulations!!! ​

Thanks for your great support for a successful ANDA filing, especially to the publishing team. Heartfully appreciate their last hours of hard work.

Assistant Manager​

US-based, Leading, Complex Generic Pharmaceutical Products Company​

 

Medicinal Products

Regulatory Affairs

USA

Thank you all for the great support!​

CEO

US-based, Leading Innovative Pharmaceuticals Company​

 

Medicinal Products

Regulatory Affairs

USA

The ANDA receipt has been received! Thank you very much for your hard work, patience, and support for our work over the last couple of months. We are delighted that we were able to meet the timeline and hit an important corporate goal of our young company. ​

Thank you again, and we look forward to working with your team on the next project!

Senior Director of Business and Product Development​

US-based, Leading Innovator Pharmaceuticals Company​